OpenAlex
PricingAboutJobs
Log inGet started
Work

Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options

HTML

Year: 2015
Type: review
Source: Expert Opinion on Pharmacotherapy
DOI: 10.1517/14656566.2016.1118055
Authors: Maria-Corina Serban, Maciej Banach, Dimitri P Mikhailidis
Institutions: University of Alabama at Birmingham, Victor Babeș University of Medicine and Pharmacy Timișoara, Medical University of Lodz, The Royal Free Hospital, University College London
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: IMPROVE-IT trial, ezetimibe, simvastatin, LDL cholesterol lowering, statin intolerance, residual cardiovascular risk, lipid-lowering therapy, PCSK9, cholesteryl ester transfer protein, triglycerides, HDL cholesterol, lipoprotein(a), fibrinogen, C-reactive protein, cardiovascular events
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2204366635
FWCI: 1.537
Cites: 108
Cited by: 46
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security